Imunon press release (NASDAQ:IMNN): Q2 GAAP EPS of -$2.15 beats by $2.61.
As of June 30, 2025, cash and cash equivalents were $4.7 million. During July 2025, the Company received $3.1 million in net proceeds from the exercise of warrants and sales under its ATM facility. The Company believes it has sufficient capital resources to fund its planned operations into the fourth quarter of 2025.